GiveBetter x California

Breathe Southern California

Asthma support, lung-health education and clean-air advocacy

Research time: ~12 min on GPT-6 Astra Light + ~2 min on GPT-6.1 Sol
  • Research — reviewed programs, finances and impact evidence.
  • Source audit — checked claims, assumptions and calculations.
  • Modeling — estimated costs, QALYs and uncertainty.

Updated: 2026-10-07

Donate

Summary

What do they do? Breathe Southern California combines asthma support with education, equipment and air-quality advocacy. BEAM serves eligible residents of Los Angeles and San Bernardino counties, both within California. The estimate prices only the BEAM health component at full recipient cost; other portfolio health remains unpriced.

Why we’re interested in this organization:

  • A current insured asthma pathway and original accounts establish real operations and recipient-scale costs.

  • Home-asthma randomized evidence supplies a finite symptom-day bridge instead of equating visits with health.

  • Named LA purifier distribution locations and public-agency response documents make geography and substitution questions concrete.

Our main reservations:

  • Insurer-covered asthma and a separate public purifier program may replace services credited to private gifts.

  • The priced BEAM pathway omits potentially important purifier and policy effects, so it is not a complete portfolio ranking.

  • Annual marginal patients, county mix, effective purifier use and health-relevant exposure reductions are unknown; past matching claims are not current offers.

What do you get for your dollar? $22.4M per DALY in California. DALY is our one-year comparison unit. QALY-based health gains and income-welfare equivalents retain their original assumptions; they are not measured clinical DALYs. Conditional BEAM health and signed household resources; workforce and other portfolio unknown.

100 annual course opportunities is a judgment, not observed run-rate. After b=.25,25 additional California reference courses; each yields 0.01 discounted QALYs under the subjective clinical bridge, total .136529126214. Other portfolio outcomes unpriced.

1. What do they do?

Breathe Southern California, EIN 95-1641451, is distinct from similarly named Northern California organizations. The current BEAM eligibility requires residence in Los Angeles or San Bernardino County. Both are inside the California edition. Accordingly, g_CA=1 applies to the modeled eligible BEAM branch, conditional on eligibility being followed; it is not the whole portfolio's geographic share. The current homepage reports 300-plus BEAM patients during 2024–2026, not annual or gift-induced throughput.

The recipient also operates purifier response, education and policy work. Those pathways may matter substantially but require separate exposure and implementation models; devices, maps and workshop counts are not QALYs.

2. Monitoring and information sharing

A randomized King County study of 373 Medicaid-enrolled children found an additional 2.10 symptom-free days per two weeks (95% CI 1.17–3.05) and 1.31 fewer urgent-care events over 12 months. Its structured multi-contact intervention differs from a visit with optional follow-up. Outcomes included self-report, and caregiver questionnaire points are not preference-based QALYs. Randomized Medicaid childhood-asthma home-visit outcomes and costs

The adult HomeBASE trial similarly improved symptom-free days and asthma-related quality of life but did not improve unscheduled health-care use. This supports a morbidity pathway while cautioning against automatically assigning hospitalization savings or childhood effects to every adult. HomeBASE randomized adult asthma trial

For BEAM, request unique-patient baseline severity, completed visits and supplies, symptom days or validated utility at follow-up, hospital claims, retention and alternative-provider availability. Compare against contemporaneous usual care and avoid selecting only high-utilization patients at a temporary peak. The public workshop page describes instruction, not controlled follow-up demonstrating fewer exacerbations. Lung Power education workshops

3. Qualitative assessment

The clinical and environmental pathways are plausible, but their marginal funding mechanisms differ. A new gift might support navigation for otherwise unserved patients, effective filter use or people outside a public program's footprint. That hypothesis needs a costed queue and comparison against services already available.

The public Palos response distinguishes the June smoke episode from ongoing cleanup monitoring and odors. It reports up to $5 million additional purifier funding, direct shipment and three years of replacement filters for eligible residents. This is an alternative-provider counterfactual—not funding received by Breathe. It makes gross distribution counts a particularly weak proxy for private-donation impact.

The organization's LinkedIn account reports thousands of purifiers and a matching appeal ending September 4; the exact post date and subsequent fulfillment are unverified. That deadline has passed, so no active match or remaining donor gap is assumed. AAFA's partner account documents an order of 300 upgraded Rabbit Air units, not that the entire shipment was donated. The policy portfolio needs its own finite exposure and coalition-attribution model.

Net resources require actual avoided spending or retained earnings after taxes, withdrawn benefits, commuting, training opportunity costs and administration. Positive overlap applies only gains; unavoidable negative costs remain in full regardless of clinical response. Insurer/public-provider costs require separate incidence from household cash.

4. What do you get for your dollar?

Conditional signed reference: about $22.4M per DALY, combining unchanged 0.14 California clinical QALYs with −0.006069 household-resource equivalents at the annual $2,923,727 full-recipient scale. Income equivalents are welfare comparisons, not clinical QALYs. The original health-only $21.4M reference and all original scenarios remain diagnostics. These are partial conditional models, not measured unrestricted-gift returns or comprehensive portfolio estimates.

The conditional BEAM estimate is $21.4M per DALY, charging $2,923,727 full recipient FY2025 expense. It is partial health, not a whole-portfolio expected return. The model posits 100 annual courses, 25% funding responsiveness, half the external trial symptom-day effect, 75% within-year timing and 0.10 utility per additional symptom-free day. At one year and 3% discount it yields 0.14 California QALYs. All eligibility counties are in California; no observed geographic population weighting is claimed.

The current cumulative count does not establish annual throughput or a funding gap. The clinical bridge gives 0.01 QALY per additional course, with no mortality, permanent cure or duplicate hospitalization effect. Joint positive scenarios, zero and adverse stress retain uncertainty. Original FY2023–25 returns have now been reopened in the shared LA evidence and no separately netted direct costs were identified; the three comparable expense amounts remain $2,075,948, $2,305,383 and $2,923,727. Outside medical, insurer and partner resources are separate societal costs.

The current BEAM page says eligible Medi-Cal services are free; its $7,500 lifetime payable maximum is coverage, not household cash. We count no copayment or covered-care retail value as consumption. Doctor referral, enrollment and home visits can require time and administrative effort, but the page supplies no dollar amount. BEAM

The illustrative resource central applies a hypothetical $10 incremental first-year administration/time burden to all 25 additional courses at a $20,000 annual resource baseline. Clinical effect transfer and within-year symptom timing do not reduce accessed-household burdens. No purchase saving is assumed centrally. Split 30% saver and 70% non-saver households; both central groups lose $10, using 0.5 times each group divided by 1.03 times log(1−10/20000), then sum. All cash/time coefficients and the course-to-household relationship are judgments, not observed losses. Funding responsiveness is applied once, and annual cost/benefit boundaries scale together in the $100,000 gift sensitivity.

A conditional actual avoided-spending world gives 30% of households $100 before taxes and benefit withdrawal: retain 80%, apply 50% positive overlap with health/security, then subtract the full $10 burden; others retain the full negative burden. No ordinary survivor earnings, gross salary, retail purifier value, insurer claims savings or insurance coverage ceiling is automatically counted. Clinical-null financial-only, financial-null/unknown, no-capacity, clinical nonresponse and adverse burdens remain explicit. Public payer consumption loss and additional real-resource expense are alternative financing scopes, never the same transfer twice.

Green-jobs activities connect residents to EV/charging training, certifications, apprenticeships and placement information through partners. No unique graduates, sustained employment, counterfactual earnings or net household resources were established. Workforce, purifier operation, energy/transport and policy pathways remain unknown, rather than zero. Green jobs

Model, assumptions and sensitivity

Ordinary gift/full recipient annual cost normalization, not a restricted BEAM or emergency-purifier gift. Latest annual cost is historical and predates 2026 response; insurer/public resources not subtracted.

Both named BEAM eligibility counties are in California; g_CA=1 conditional on compliance. A .95 sensitivity allows eligibility/movement leakage. This is independently scoped, not a copy of the LA model's .5 county-share judgment.

QCA=(D/C)*N*b*(deltaSFD14/14)*deltaU*r*w*T*gCA/(1+d); C=2923727,N=100,b=.25,deltaSFD14=2.1,deltaU=.1,r=.5,w=.75,T=1,gCA=1,d=.03. Price10=10*D/QCA. Purifier and policy health unpriced; no automatic portfolio uplift. Household people=(D/C)*N*b*g, without clinical transfer/timing discounts. Joint saver/non-saver groups receive positive actual avoided spending after retention/overlap and FULL negative admin/time burden; income=.5*sum(groupPeople/(1+d)*log1p(net/before)), year1 only. Annual cost/people boundaries match; hypothetical gift100000 scales both.

C
2923727 USD annual recipient expenses (observed). FY 2025 original accrual return; predates 2026 response. [990-25]
N
100 annual BEAM courses, diagnostic (judgment). 300-plus cumulative patients over 2024–2026 divided by three calendar-year labels; not an observed annual run-rate. [home]
b
0.25 marginal funding responsiveness (judgment). Possible navigation/capacity margin after payer/provider substitution; no verified gap. [beam] [chw]
g
1 California share of eligible BEAM benefit (judgment). Both Los Angeles and San Bernardino counties are in California. Conditional on residence eligibility; .95–1 test, not all-portfolio attribution. [beam]
deltaSFD14
2.1 symptom-free days per fortnight (observed). External childhood RCT benchmark; not BEAM. [rct]
deltaU
0.1 utility difference on extra symptom-free day (judgment). Preference-weight bridge not measured for BEAM.
r
0.5 trial effect retained (judgment). Adult/child mix, visit intensity and modern usual care differ. [rct] [adult]
w
0.75 within-year effect timing retained (judgment). Avoid full endpoint effect credited before treatment.
T
1 years (judgment). No later years or asthma cure credited.
d
0.03 annual discount rate (judgment). One-year discount on finite morbidity benefit.
Q_filter_CA
unknown incremental California QALYs (unknown). Need unique effective use, additionality relative to AQMD and existing stock, pollutant exposure and duration; not filter count. [events26] [palos] [hepa-rct]
Q_policy_other_CA
unknown incremental California QALYs (unknown). Need finite implementation/dose/coalition bridge. [advocacy]
publicPurifierFunding
5000000 USD additional approved funding ceiling (observed). AQMD program, not Breathe funding or actual expenditures; substitution context only. [palos]
resource-saverShare
0.3 resource coefficient (judgment). Explicit hypothetical household coefficient; BEAM establishes free insured services and referral process, not measured savings, time cost or income effect. [beam]
resource-savings
0 USD (judgment). Explicit hypothetical household coefficient; BEAM establishes free insured services and referral process, not measured savings, time cost or income effect. [beam]
resource-netRetained
0.8 resource coefficient (judgment). Explicit hypothetical household coefficient; BEAM establishes free insured services and referral process, not measured savings, time cost or income effect. [beam]
resource-positiveShare
0.5 resource coefficient (judgment). Explicit hypothetical household coefficient; BEAM establishes free insured services and referral process, not measured savings, time cost or income effect. [beam]
resource-burden
10 USD (judgment). Explicit hypothetical household coefficient; BEAM establishes free insured services and referral process, not measured savings, time cost or income effect. [beam]
resource-before
20000 USD (judgment). Explicit hypothetical household coefficient; BEAM establishes free insured services and referral process, not measured savings, time cost or income effect. [beam]

Original health-only diagnostic: Judgment best estimate: BEAM health at full recipient cost: Cost: $2.9M; California health QALYs: 0.14; all-population health QALYs: 0.14. N = 100; b = 0.25; gCA = 1; deltaSFD14 = 2.1; deltaU = 0.1; r = 0.5; w = 0.75; T = 1; d = 0.03.

Original health-only diagnostic: Weak annual delivery, responsiveness and health transfer: Cost: $2.9M; California health QALYs: 0.00; all-population health QALYs: 0.00. N=30; b=.05; deltaSFD14=2.1; deltaU=.03; r=.2; w=.5; T=1; gCA=.95; d=.03. Joint judgment stress case, not confidence limits.

Original health-only diagnostic: Strong asthma margin and local share; not confidence bound: Cost: $2.9M; California health QALYs: 6.55; all-population health QALYs: 6.55. N = 300; b = 0.75; gCA = 1; deltaU = 0.2; r = 1; w = 1. Other clinical assumptions are unchanged.

Original health-only diagnostic: Full substitution or no health improvement: Cost: $2.9M; California health QALYs: 0.00; all-population health QALYs: 0.00. No additional health beyond existing payer/public/private provision.

Original health-only diagnostic: Unquantified adverse net effect remains possible: Cost: $2.9M; California health QALYs: unknown; all-population health QALYs: unknown. Ineffective use, exposure substitution and harmful policy trade-offs not assigned a fabricated negative bound.

Original health-only diagnostic: Illustrative net harm, not a measured bound: Cost: $2.9M; California health QALYs: -0.10; all-population health QALYs: -0.10. A net 0.10 California QALY loss from displaced care or adverse effects; explicit stress test, not observed.

Original health-only diagnostic: Unpriced remaining portfolio pathways: Cost: $2.9M; California health QALYs: unknown; all-population health QALYs: unknown. Purifier response and policy may add or subtract health; no invented amount is added to the BEAM estimate.

central: Cost: $2.9M; California health QALYs: 0.14; all-population health QALYs: 0.14. Income-equivalent healthy years: -0.01. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

financial-null: Cost: $2.9M; California health QALYs: 0.14; all-population health QALYs: 0.14. Income-equivalent healthy years: 0.00. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":0,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

clinical-null-negative-cash: Cost: $2.9M; California health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: -0.01. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

income-unknown: Cost: $2.9M; California health QALYs: 0.14; all-population health QALYs: 0.14. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

no-capacity: Cost: $2.9M; California health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. {"D":2923727,"C":2923727,"N":100,"b":0,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

no-clinical-response: Cost: $2.9M; California health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: -0.01. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

adverse-burdens: Cost: $2.9M; California health QALYs: 0.14; all-population health QALYs: 0.14. Income-equivalent healthy years: -0.06. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":100,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

conditional-avoided-spending: Cost: $2.9M; California health QALYs: 0.14; all-population health QALYs: 0.14. Income-equivalent healthy years: 0.00. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":100,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

clinical-null-financial-only: Cost: $2.9M; California health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":100,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

disjoint-public-consumption: Cost: $2.9M; California health QALYs: 0.14; all-population health QALYs: 0.14. Income-equivalent healthy years: -0.01. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":1,"payerLoss":100,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

additional-real-resource-cost: Cost: $3.0M; California health QALYs: 0.14; all-population health QALYs: 0.14. Income-equivalent healthy years: -0.01. {"D":2923727,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":100000}; conditional household judgments, not measured causal net income.

gift-100000-proportional: Cost: $100K; California health QALYs: 0.00; all-population health QALYs: 0.00. Income-equivalent healthy years: 0.00. {"D":100000,"C":2923727,"N":100,"b":0.25,"sfd":2.1,"u":0.1,"r":0.5,"w":0.75,"T":1,"g":1,"d":0.03,"saverShare":0.3,"savings":0,"netRetained":0.8,"positiveShare":0.5,"burden":10,"before":20000,"payerPeople":0,"payerLoss":0,"payerBefore":50000,"externalCost":0}; conditional household judgments, not measured causal net income.

Counterfactual: Medi-Cal asthma preventive services/Community Supports, alternative providers, existing purifiers, AQMD funded distribution, donors and partner resources continue absent a new gift. A gift cannot retroactively change June smoke exposure, past distributions or an expired match.

Attribution: b is a subjective marginal responsiveness factor combining recipient allocation/capacity and substitution; clinical r and within-year w are separate. Do not apply both BEAM multimodal symptom gains and filtration gains to the same patient's same symptoms. Policy benefits need coalition counterfactual and geographic exposure allocation.

Finite judgment best estimate with broad joint scenarios, zero and harm. Unknown observed marginal inputs do not require suppressing the priced asthma pathway. The central is partial health at full gift cost, not a measured unrestricted-portfolio expectation. The utility prior represents expected net health area over the stated finite horizon, including treatment burden, within-horizon fade and competing mortality; it is not an endpoint score held indefinitely. No survival extension is credited. Signed resource amounts, baseline and saver share are judgments. Free BEAM is not a patient copayment pathway. Green-jobs realized net earnings and remaining portfolio resources remain unknown.

Sensitivity

  • Central partial-health price $21.4M per DALY; low/high joint scenarios are subjective, not confidence bounds.
  • The California denominator includes eligible San Bernardino residents excluded in LA. The same underlying benefits must not be summed across editions.
  • 100 annual courses is weakly anchored to 300-plus cumulative patients across three calendar labels; actual annual throughput may differ.
  • Clinical transfer, within-year timing, utility and funding response dominate; no trial completion or payer substitution multiplier is added twice.
  • No lifetime asthma cure, overlapping purifier symptom benefit or unpriced policy uplift.
  • Signed resources retain full negative access costs, clinical-null financial effects and unknown workforce resources; no insurer coverage cap treated as income.

Unresolved inputs

  • Current unrestricted allocation, grant restrictions and costed unmet queue across asthma and purifier response.
  • Unique annual BEAM courses by county, completed service intensity and alternative payer/provider response.
  • Purifier households not already covered by AQMD, effective operating time, clean-air delivery, pollutant-specific exposure and health benefit.
  • Current post-September 4 appeal status; no active match established.
  • Finite policy health and geography model, avoiding attribution of all California burden to one coalition member.
  • Actual incremental enrollment/home-visit time and administration costs, avoided household expenditure relative to free alternative supply; unique participating households; workforce referrals, sustained placement, net earnings after taxes/benefits/commuting/opportunity costs; public payer incidence.

Health and income breakdown

For the modeled $2.9M: 0.14 health QALYs + -0.01 income-equivalent healthy years in California: $22.4M per DALY. Income equivalents are welfare comparisons, not observed QALYs or DALYs.

Method and caveats.

5. Funding and previous grants

Original accrual returns for fiscal years ending June report expenses of $2,075,948 in 2023, $2,305,383 in 2024 and $2,923,727 in 2025: a three-year mean of $2,435,019.33. The 2024 return supplies the 2023 comparative. Its $4,719,274 revenue included $2,441,575 miscellaneous income; that unusually large category should not be assumed recurring clinical revenue. Original Form 990, fiscal year ending June 2024 with 2023 comparative totals

For 2025, revenue was $2,573,083, including $1,527,260 contributions and $814,003 rent. The return classifies every expense as program, with zero management/fundraising allocation; this does not establish zero overhead. It reports no independent financial-statement audit. Net assets were $10,700,896, including $4,612,972 restricted; Schedule O labels a $1,092,063 reconciliation addition only as a book/tax difference. Those facts merit clarification rather than interpreting the $350,644 revenue-expense deficit as proof that every gift funds additional care. Original Form 990, fiscal year ending June 2025

Government-grant and program-fee rows on that historical return do not negate the current contracts on the BEAM page. Detailed payer receipts, current BEAM cost centers and contract reimbursement margins are needed before allocating ordinary donations. BEAM services, eligibility, counties and managed-care contracts

DHCS's finalized update removes assessment and self-management education from the Asthma Remediation Community Support beginning January 2026 because the Asthma Preventive Services benefit covers them; physical supplies and modifications remain complementary remediation services. This is a separation to avoid duplication, not elimination of all asthma support. The old all-in-one description should not be used to infer a new donor gap or a flat payment received for each patient. Final asthma-remediation definitions and January 2026 benefit separation

Current DHCS resources describe a provider enrollment pathway for community organizations delivering asthma preventive services. A gift might improve access, pay unreimbursed navigation or serve people otherwise excluded, but a costed unmet queue and the alternative plan/provider response were not found. Current CHW and asthma provider enrollment resources

Annual expenses

Organization-level spending, including programs, administration and fundraising. The research list averages three comparable, consecutive full fiscal years when available.

  • FY 2023: $2.1M; Breathe Southern California, EIN 95-1641451, 12-month period, Accrual Form 990 total expenses; fiscal year ending June 30; no separately netted direct costs identified. Source
  • FY 2024: $2.3M; Breathe Southern California, EIN 95-1641451, 12-month period, Accrual Form 990 total expenses; fiscal year ending June 30; no separately netted direct costs identified. Source
  • FY 2025: $2.9M; Breathe Southern California, EIN 95-1641451, 12-month period, Accrual Form 990 total expenses; fiscal year ending June 30; no separately netted direct costs identified. Source

6. Sources

  1. Current portfolio and cumulative service counts. Breathe Southern California. Published: not stated; retrieved: 2026-09-14.
  2. BEAM services, eligibility, counties and managed-care contracts. Breathe Southern California. Published: not stated; retrieved: 2026-10-07.
  3. Lung Power education workshops. Breathe Southern California. Published: not stated; retrieved: 2026-09-13.
  4. Current advocacy portfolio and historical campaigns. Breathe Southern California. Published: not stated; retrieved: 2026-09-13.
  5. Ordinary donation route. Breathe Southern California via Zeffy. Published: not stated; retrieved: 2026-09-13.
  6. Randomized Medicaid childhood-asthma home-visit outcomes and costs. Campbell et al., American Journal of Public Health. Published: not stated; retrieved: 2026-09-13.
  7. HomeBASE randomized adult asthma trial. Krieger et al., JAMA Internal Medicine. Published: not stated; retrieved: 2026-09-13.
  8. Final asthma-remediation definitions and January 2026 benefit separation. California DHCS. Published: not stated; retrieved: 2026-09-13.
  9. Current CHW and asthma provider enrollment resources. California DHCS. Published: not stated; retrieved: 2026-09-13.
  10. Chaptered AB 1003 text. California Legislature. Published: 2025-10-13; retrieved: 2026-09-13.
  11. Original Form 990, fiscal year ending June 2025. Breathe Southern California / IRS via ProPublica. Published: not stated; retrieved: 2026-09-14.
  12. Original Form 990, fiscal year ending June 2024 with 2023 comparative totals. Breathe Southern California / IRS via ProPublica. Published: not stated; retrieved: 2026-09-14.
  13. Official 2026 community events and purifier eligibility. Breathe Southern California. Published: not stated; retrieved: 2026-09-14.
  14. Building-decarbonization support. Breathe Southern California. Published: not stated; retrieved: 2026-09-14.
  15. BlueSky LA programs. Breathe Southern California. Published: not stated; retrieved: 2026-09-14.
  16. 2026 Palos Fire / Lineage Cleanup and Recovery; public purifier funding. South Coast AQMD. Published: not stated; retrieved: 2026-09-14.
  17. Organization-authored purifier response and past matching appeal; post date unverified. Breathe Southern California via LinkedIn. Published: not stated; retrieved: 2026-09-14.
  18. AAFA 2026 certified-partner community response. AAFA / Asthma & Allergy Friendly. Published: not stated; retrieved: 2026-09-14.
  19. HEPA air cleaners: randomized asthma visit and symptom outcomes. Lanphear et al.; Pediatrics. Published: 2010-12-13; retrieved: 2026-09-14.
  20. Current IRS filing index, freshness check. ProPublica Nonprofit Explorer. Published: not stated; retrieved: 2026-09-14.
  21. Original FY2023 Form 990; accrual and netted-cost rows independently reopened. Breathe Southern California / IRS. Published: not stated; retrieved: 2026-09-14.
  22. Promoting Green Jobs: workforce connections and partnerships. Breathe Southern California. Published: not stated; retrieved: 2026-10-07.